Literature DB >> 10666478

Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.

P Yang1, D L Farkas, J M Kirkwood, J L Abernethy, H D Edington, D Becker.   

Abstract

BACKGROUND: The stages of melanocytic progression are defined as atypical (dysplastic) nevus, melanoma in situ, melanoma in the radial growth phase (RGP), melanoma in the vertical growth phase (VGP), and melanoma in the metastatic growth phase (MGP). Melanoma in situ and RGP melanoma often develop in contiguous association with atypical nevi. This frequently poses a problem with respect to their early detection. Furthermore, unlike cells obtained from VGP and MGP melanomas, cells derived from melanoma in situ and RGP melanoma do not proliferate in vitro. Thus, compared to the late stages of the disease, less information is available regarding genes expressed in the early stages.
MATERIALS AND METHODS: To determine whether spectral imaging, a recently developed optical imaging technique, can detect melanoma in situ and RGP melanoma arising in melanoma precursor lesions, atypical nevi in patients with a clinical history of melanoma were subjected to noninvasive macroscopic spectral imaging. To determine at what stage in the progression pathway of melanoma genes having important biological functions in VGP and MGP melanomas are activated and expressed, lesions of melanoma in situ were analyzed by immunohistochemistry and in situ hybridization for expression of some of these known molecular and immunologic markers.
RESULTS: The present study demonstrates the capability of noninvasive spectral imaging to detect melanoma in situ and RGP melanoma that arise in contiguous association with atypical nevi. Furthermore, the study provides evidence that genes and antigens expressed in VGP and MGP melanoma are also expressed in melanoma in situ.
CONCLUSIONS: Because of the dark and variegated pigmentation of atypical nevi, melanoma in situ and RGP melanoma that arise in these melanoma precursor lesions are often difficult to recognize and thus frequently go unnoticed. The application of new optical screening techniques for early detection of melanoma and the identification of genes expressed in the early stages of melanoma development are two important avenues in the pursuit of melanoma prevention. The investigations presented here document that macroscopic spectral imaging has the potential to detect melanoma in its early stage of development and that genes essential for the proliferation and cell adhesion of VGP and MGP melanoma are already expressed in melanoma in situ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10666478      PMCID: PMC2230496     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  16 in total

1.  Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth.

Authors:  Y Wang; D Becker
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  Non-invasive image acquisition and advanced processing in optical bioimaging.

Authors:  D L Farkas; C Du; G W Fisher; C Lau; W Niu; E S Wachman; R M Levenson
Journal:  Comput Med Imaging Graph       Date:  1998 Mar-Apr       Impact factor: 4.790

3.  In vivo cellular optical coherence tomography imaging.

Authors:  S A Boppart; B E Bouma; C Pitris; J F Southern; M E Brezinski; J G Fujimoto
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

4.  AOTF microscope for imaging with increased speed and spectral versatility.

Authors:  E S Wachman; W Niu; D L Farkas
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

5.  Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

Authors:  J M Kirkwood; D L Farkas; A Chakraborty; K F Dyer; D J Tweardy; J L Abernethy; H D Edington; S S Donnelly; D Becker
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

6.  Molecular analysis of melanoma precursor lesions.

Authors:  Y Wang; U Rao; R Mascari; T J Richards; A J Panson; H D Edington; J M Shipe-Spotloe; S S Donnelly; J M Kirkwood; D Becker
Journal:  Cell Growth Differ       Date:  1996-12

7.  Shifts in cadherin profiles between human normal melanocytes and melanomas.

Authors:  M Y Hsu; M J Wheelock; K R Johnson; M Herlyn
Journal:  J Investig Dermatol Symp Proc       Date:  1996-04

Review 8.  The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.

Authors:  D E Elder; W H Clark; R Elenitsas; D Guerry; A C Halpern
Journal:  Semin Diagn Pathol       Date:  1993-02       Impact factor: 3.464

9.  Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.

Authors:  D Becker; C B Meier; M Herlyn
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro.

Authors:  A Tang; M S Eller; M Hara; M Yaar; S Hirohashi; B A Gilchrest
Journal:  J Cell Sci       Date:  1994-04       Impact factor: 5.285

View more
  9 in total

1.  New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Authors:  Meenhard Herlyn; Martin Padarathsingh; Lynda Chin; Mary Hendrix; Dorothea Becker; Mark Nelson; Yves DeClerck; James McCarthy; Suresh Mohla
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 2.  [Cytomics and predictive medicine for oncology].

Authors:  A O H Gerstner; W Laffers
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

3.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Natalie M Barkey; Narges K Tafreshi; Jatinder S Josan; Channa R De Silva; Kevin N Sill; Victor J Hruby; Robert J Gillies; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2011-11-10       Impact factor: 7.446

Review 4.  Probing physiology and molecular function using optical imaging: applications to breast cancer.

Authors:  V Ntziachristos; B Chance
Journal:  Breast Cancer Res       Date:  2000-11-29       Impact factor: 6.466

5.  Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe data.

Authors:  Timothy E Renkoski; Kenneth D Hatch; Urs Utzinger
Journal:  J Biomed Opt       Date:  2012-03       Impact factor: 3.170

Review 6.  Biomedical Applications of Translational Optical Imaging: From Molecules to Humans.

Authors:  Daniel L Farkas
Journal:  Molecules       Date:  2021-11-02       Impact factor: 4.411

7.  Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Narges K Tafreshi; Xuan Huang; Valerie E Moberg; Natalie M Barkey; Vernon K Sondak; Haibin Tian; David L Morse; Josef Vagner
Journal:  Bioconjug Chem       Date:  2012-11-27       Impact factor: 4.774

8.  Early detection in head and neck cancer - current state and future perspectives.

Authors:  Andreas O H Gerstner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2010-10-07

9.  Polarization-sensitive hyperspectral imaging in vivo: a multimode dermoscope for skin analysis.

Authors:  Fartash Vasefi; Nicholas MacKinnon; Rolf B Saager; Anthony J Durkin; Robert Chave; Erik H Lindsley; Daniel L Farkas
Journal:  Sci Rep       Date:  2014-05-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.